Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-IgG) (BSIG-177)

Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL1α and anti-IL1β parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Osteoarthritis (OA) therapy.

Datasheet INQUIRY

Specifications

Targets

IL1α & IL1β

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Osteoarthritis (OA)

Targets

Target 1

IL1α

Gene ID

3552

UniProt ID

P01583

Alternative Names

IL1; IL-1A; IL1F1; IL1-ALPHA; Interleukin 1 alpha; hematopoietin 1; IL1α

Target 2

IL1β

Gene ID

3553

UniProt ID

P01584

Alternative Names

IL-1; IL1F2; IL1-BETA; IL1β; Interleukin-1β; IL-1β

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-IgG) (BSIG-177). Click the button below to contact us or submit your feedback about this product.

Anti-IL1α x Anti-IL1β Bispecific Antibody (IgG-IgG) (CAT#: BSIG-177)

Specifications

Targets

Customer Reviews and Q&As